# ClinicalTrials.gov record NCT01951651

> PeptideScanner retained ClinicalTrials.gov record NCT01951651 at 2026-07-30T21:37:20.824Z. Its registry update date was 2016-05-16, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct01951651-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-05-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01951651-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01951651-exenatide-v1.json
- Content SHA-256: `6de9c0594563c7aa6263aee0388181b47a7c28631fea24d4a379929c1d5a1888`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01951651 ([`ctg-observation-nct01951651-2016-05-16-7714ac7cac3c`](#source-ctg-observation-nct01951651-2016-05-16-7714ac7cac3c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01951651 at 2026-07-30T21:37:20.824Z. Its registry update date was 2016-05-16, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01951651-2016-05-16-7714ac7cac3c`](#source-ctg-observation-nct01951651-2016-05-16-7714ac7cac3c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01951651 at 2026-07-30T21:37:20.824Z. Its registry update date was 2016-05-16, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01951651-2016-05-16-7714ac7cac3c`](#source-ctg-observation-nct01951651-2016-05-16-7714ac7cac3c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01951651-2016-05-16-7714ac7cac3c`](#source-ctg-observation-nct01951651-2016-05-16-7714ac7cac3c))

## Sources

<a id="source-ctg-observation-nct01951651-2016-05-16-7714ac7cac3c"></a>
- **ClinicalTrials.gov record NCT01951651 · retained source version 2016-05-16:7714ac7cac3cdd9de5955464f9fd0c2df4143272304bb67cf17c318ce33a0048** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01951651) (`ctg-observation-nct01951651-2016-05-16-7714ac7cac3c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01951651." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01951651-exenatide-v1.json SHA-256: 6de9c0594563c7aa6263aee0388181b47a7c28631fea24d4a379929c1d5a1888.